AEterna Zentaris Inc. (NASDAQ: AEZS) announced the signing of a development, commercialization and licensing agreement with sanofi-aventis (NYSE: SNY) for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE